BayMark Health Services Executive and Leadership Team

David White, the Chief Executive Officer at BayMark Health Services, directs the overarching strategy and operational execution for the organization. White's leadership ensures the company's continued focus on providing evidence-based, individualized treatment services for individuals struggling with opioid addiction. Overseeing all major corporate initiatives, the Chief Executive Officer drives the expansion of services and maintains the integrity of the company's mission. This executive role involves aligning departmental goals with the core objective of patient recovery and long-term success. By fostering a culture of excellence and innovation, David White guides BayMark Health Services in its critical work across the United States, solidifying its position as a leader in addiction treatment.

Bruce Jarvie, the Chief Financial Officer at BayMark Health Services, directs all financial planning, management, and reporting activities for the organization. Jarvie ensures the fiscal health and sustainability of BayMark's operations, which are dedicated to providing specialized opioid addiction treatment. This role encompasses managing budgets, overseeing investments, and optimizing financial performance across all service lines. The Chief Financial Officer is integral to securing the resources necessary for expanding treatment access and maintaining the highest standards of care. By implementing sound financial strategies, Bruce Jarvie supports the company's mission to deliver effective, evidence-based services. Jarvie's oversight guarantees that financial operations align with the organization's commitment to patient recovery and long-term growth.

Stephanie Madrid, the Group President, Residential Treatment Services at BayMark Health Services, oversees the strategic development and operational management of the company's residential treatment facilities. Madrid ensures these centers provide comprehensive, evidence-based care for individuals overcoming opioid addiction. This leadership position involves driving program quality, enhancing patient experience, and optimizing the delivery of individualized treatment plans. The Group President, Residential Treatment Services works to expand the reach and effectiveness of these crucial services across various regions. By focusing on operational excellence and clinical integrity, Stephanie Madrid directly supports BayMark's mission to foster recovery and improve lives. Madrid's dedication ensures that residential programs meet the highest standards of care.

Jason Kletter, the President at BayMark Health Services, drives the overall strategic direction and operational effectiveness of the organization. Kletter's leadership ensures BayMark Health Services remains at the forefront of providing evidence-based, individualized treatment for opioid addiction. This executive role involves overseeing key business functions and fostering growth across all service lines. The President is instrumental in shaping the company's approach to patient care and expanding its national footprint. By championing innovation and operational excellence, Jason Kletter guides the organization in its mission to support recovery and improve community health. Kletter's focus is on ensuring the sustained delivery of high-quality addiction treatment services.

Michael Minks, the Chief Information Officer at BayMark Health Services, architects and manages the organization's technology infrastructure and digital strategy. Minks ensures that all information systems support the delivery of high-quality, evidence-based opioid addiction treatment services. This involves overseeing data security, electronic health records, and the integration of new technologies to enhance patient care and operational efficiency. The Chief Information Officer plays a crucial part in leveraging data analytics to inform treatment protocols and organizational decision-making. By driving technological advancements, Michael Minks supports the company's mission to provide accessible and effective care nationwide. Minks's focus remains on maintaining robust IT operations that directly contribute to patient outcomes and organizational growth.

Sergio Huerta, the Chief Medical Officer, OTP Western Region at BayMark Health Services, leads the medical direction and clinical oversight for opioid treatment programs across the western United States. Huerta ensures the consistent application of evidence-based medical practices and individualized treatment plans for patients battling opioid addiction. This critical role involves guiding clinical teams, maintaining regulatory compliance, and advancing the quality of care delivered. The Chief Medical Officer, OTP Western Region champions the integration of the latest medical research into treatment protocols. By focusing on clinical excellence, Sergio Huerta directly contributes to improved patient outcomes and the expansion of effective addiction services. Huerta's expertise is vital in upholding BayMark's commitment to patient recovery and well-being.